Revenue

Ahead of its March 3 earnings call, 908 Devices' strong preliminary results and focus on handheld tech signal a pivotal year for the security innovator.

A new partnership gives UnionPay cardholders access to 13,000 UK ATMs, a strategic move to capture high-value tourist spending and reinforce cash's role.

Sanborn's Dr. Srini Dharmapuri has been named an ASPRS Fellow for his work on accuracy standards and digital twins, shaping the future of geospatial data.

A new report reveals why some indie restaurants thrive while others struggle, and it’s not just hard work. It's about access to strategic tools.

A fatal crash and a spike in deaths have prompted a stark warning: the mix of jets, helicopters, and drones in our airspace is a growing global threat.

Shutterstock posts record 2025 revenue on AI data growth, but a steep Q4 loss and merger costs reveal deep challenges in its core content business.

eToro reports a record $868M in 2025 net contribution and adds $100M to its buyback, betting on AI and its super-app vision despite a Q4 crypto lull.

India's car-sharing leader posts a record quarter, slashing losses by 91% without marketing spend, and now eyes a US market uplisting and new capital.

As Xtract One readies its Q2 results, investors eye its booming backlog against a backdrop of rising competition and ethical questions in AI security.

Ascend Elements' award to TDK Ventures reveals a new VC model, where hands-on partnership is key to building a secure, circular battery supply chain.

Tech giant Sony secures access to crucial 5G, Wi-Fi, and video patents, renewing a long-standing agreement with R&D powerhouse InterDigital.

As millions of fans plan for the 2026 World Cup, a new tool aims to simplify the hunt for affordable flights across North America's host cities.

A new strategic partnership aims to tame satellite network complexity by integrating G&S SatConnect® into ST Engineering iDirect’s Intuition platform.

Fresh off a $1.1B IPO and a #1 GreenTech ranking, BETA Technologies faces investors to prove its electric aviation vision is commercially viable.

Now debt-free with $14M in cash, Castellum is leveraging major Navy contracts to fuel its next phase of expansion through acquisitions and innovation.

Fortrea splits key roles, dedicating its CMO to scientific strategy and hiring a new president for clinical pharmacology in a bold post-spin-off move.

Cyclerion's novel therapy for treatment-resistant depression, using EEG-guided anesthesia, gains key FDA support and a top-tier advisory board.

Warner Bros. Discovery pushes for a Netflix merger but opens a one-week window for Paramount Skydance to fix its flawed bid. A bidding war looms.

With a key depression drug nearing Phase 3 and more data imminent, AtaiBeckley is set to make its case to Wall Street at three major March conferences.

With a massive dataset from $6.2B in prior authorizations, SamaCare's AI is speeding up access to critical drugs, but raises questions about market power.